Absorption |
Blood-Brain Barrier | BBB+ | 0.9547 |
Human Intestinal Absorption | HIA+ | 0.9788 |
Caco-2 Permeability | Caco2+ | 0.6671 |
P-glycoprotein Substrate | Non-substrate | 0.8609 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9406 |
Non-inhibitor | 0.9569 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8333 |
Distribution |
Subcellular localization | Mitochondria | 0.5995 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8698 |
CYP450 2D6 Substrate | Non-substrate | 0.8905 |
CYP450 3A4 Substrate | Non-substrate | 0.7574 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8072 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9028 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9739 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9093 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9878 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8767 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8806 |
Non-inhibitor | 0.9643 |
AMES Toxicity | AMES toxic | 0.5465 |
Carcinogens | Carcinogens | 0.5322 |
Fish Toxicity | Low FHMT | 0.9398 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.9489 |
Honey Bee Toxicity | High HBT | 0.7402 |
Biodegradation | Ready biodegradable | 0.7230 |
Acute Oral Toxicity | III | 0.6311 |
Carcinogenicity (Three-class) | Non-required | 0.4156 |